Cardio Diagnostics Holdings
Closed (deSPAC)Health Care · AI-driven cardiovascular epigenetic diagnostics
- What it is
- industry and peer companies
- What it’s doing now
- Merging with Mana Capital Acquisition Corp. (MAAQ) — closed (despac).
- What you should know
- Data is still being assembled for this company — what is shown below is everything we have verified so far.
The business, per its filings
SEC primaryindustry and peer companies. Thi s d ata involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. To the fullest extent permitted by law, in no circumstances will Mana C api tal, Cardio or any of their respective subsidiaries, affiliates, representatives, directors, officers, advisers or agents be lia ble for any direct, indirect or consequential losses arising from the use of this presentation, the information contained within this presentation, or otherwise arising in connection therewith, including an y i nvestment in shares of Mana Capital or the combined entity. In addition, projections, assumptions, and estimates of Cardio’s fut ure performance and the future performance of the markets in which Cardio competes are necessarily subject to a high degree of uncertainty and risk.
Source: S-4/A, accession 0001079973-22-001293
What the company says about itself
Web research — not audited[WEB-INTEL 2026-08-26] 1 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "SPAC Mana Capital Acquisition prices $62 million IPO, led by Ladenburg MD 11/22/21" [https://www.renaissancecapital.com/Profile/CDIO/Cardio-Diagnostics/IPO] [WEB-INTEL 2026-08-26] 1 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "SPAC Mana Capital Acquisition prices $62 million IPO" [https://www.renaissancecapital.com/Profile/CDIO/Cardio-Diagnostics/IPO]
Source: company web presence · marketing claims are reported as claims, never merged into the filed figures above.
The deal it’s entering
Cardio Diagnostics Holdings is merging with Mana Capital Acquisition Corp. (MAAQ) currently marked Closed (deSPAC).
| Headline equity value | — |
How to read these numbers: headline vs effective valuation · what a definitive agreement commits
What exactly is being valued, and at what
Common questions
Is Cardio Diagnostics Holdings going public?
Cardio Diagnostics Holdings has an approved merger with the SPAC Mana Capital Acquisition Corp. (MAAQ). Deal status: Closed (deSPAC).
Does Cardio Diagnostics Holdings have revenue?
The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.
Educational content, not investment advice.
- Oak Hill Bio — with RACC ($160M) · pre-revenue
- Longevity Biomedical — with FTII ($100M) · pre-revenue
- GNQ Insilico — with IBAC ($500M)
- HCC Healthcare Pte. — with RFAM ($500M)
- OmniAb — with AHPA
- Jasper Therapeutics — with AMHC